DR info

Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61

Lennox-Gastaut syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
144	Lennox-Gastaut syndrome	-
140	Dorabe syndrome	41.250
6	Parkinson disease	38.939
13	Multiple sclerosis/Neuromyelitis optica	36.947
156	Rett syndrome	36.470
97	Ulcerative colitis	36.225
2	Amyotrophic lateral sclerosis	35.902
193	Prader-Willi syndrome	35.826
8	Huntington disease	33.328
206	Fragile X syndrome	23.520
145	West syndrome	22.639
298	Hereditary pancreatitis	21.053
18	Spinocerebellar degeneration	20.847
17	Multiple system atrophy	18.998
3	Spinal muscular atrophy	18.531
5	Progressive supranuclear palsy	17.465
70	Spinal stenosis	17.393
272	Fibrodysplasia ossificans progressiva	17.268
96	Crohn disease	16.826
36	Epidermolysis bullosa	16.524
231	Alpha-1-antitrypsin deficiency	16.200
152	PCDH19 related syndrome	16.000
46	Malignant rheumatoid arthritis	15.511
155	Acquired aphasia with convulsive disorder	13.681
201	Angelman syndrome	13.061
158	Tuberous sclerosis	12.469
205	Fragile X syndrome related disease	12.121
84	Sarcoidosis	12.073
34	Neurofibromatosis	11.897
22	Moyamoya disease	11.382
98	Eosinophilic gastrointestinal disease	10.501
21	Mitochondrial disease	9.914
296	Biliary atresia	9.056
75	Cushing disease	8.005
203	22q11.2 deletion syndrome	6.376
226	Interstitial cystitis with Hunners ulcer	4.638
149	Hemiconvulsion hemiplegia epilepsy syndrome	4.456
86	Pulmonary arterial hypertension	4.026
114	Non-dystrophic myotonia syndrome	3.333
58	Hypertrophic cardiomyopathy	3.031
168	Ehlers-Danlos syndrome	3.005
1	Spinal and bulbar muscular atrophy	2.755
51	Scleroderma	2.745
10	Charcot-Marie-Tooth disease	2.551
90	Retinitis pigmentosa	2.399
127	Frontotemporal lobar degeneration	2.050
38	Stevens-Johnson syndrome	2.007
167	Marfan syndrome	1.796
81	Congenital adrenal hyperplasia	1.551
256	Muscle glycogenosis	1.234
28	Systemic amyloidosis	1.213
202	Smith-Magenis syndrome	1.041